Connect with us

Hi, what are you looking for?


AfDB establishes African Pharmaceutical Technology Foundation to cut $14bn annual drugs importation in Africa

The Board of Directors of the African Development Bank (AfDB), has approved the establishment of the African Pharmaceutical Technology Foundation for Africa’s access to technologies.

News Agency of Nigeria

The Board of Directors of the African Development Bank (AfDB), has approved the establishment of the African Pharmaceutical Technology Foundation for Africa’s access to technologies.

According to the bank, this is for the manufacture of medicines, vaccines and other pharmaceutical products.

In a statement by the bank”s Communication and External Relations Department on Monday in Abuja, the AfDB President, Dr Akinwumi Adesina described the development as a leap for Africa.

He said, with Africa importing more than 70 per cent of all the medicines it needs and consuming 14 billion dollars per year, the establishment of the Foundation was a major development.

Adesina said “Global efforts to rapidly expand manufacturing of essential pharmaceutical products including vaccines in developing countries, particularly in Africa, to assure greater access, had been hampered.

“This has been hampered by intellectual property rights protection and patents on technological know-how, manufacturing processes and trade secrets.

“African pharmaceutical companies do not have the scouting and negotiation capacity, and bandwidth to engage with global pharmaceutical companies.

“They have been marginalised and left behind in complex global pharmaceutical innovations.”

He decried that of 35 companies which recently signed a licence with America’s Merck to produce Nirmatrelvir, a COVID-19 drug, none was African.

According to him, no institution exists in Africa to support the practical implementation of Trade-Related Intellectual Property Rights (TRIPs) on nonexclusive or exclusive licencing of proprietary technologies, know-how and processes.

He expressed optimism that the Foundation would fill existing gaps when fully established.

“It will be staffed with world-class experts on pharmaceutical innovation and development, intellectual property rights, and health policy.

“It will act as a transparent intermediator advancing and brokering the interests of the African pharmaceutical sector with global and other Southern pharmaceutical companies,” the statement said.

It quoted Adesina as saying, “Africa must have a healthy defence system, which must include three major areas.

“Revamping Africa’s pharmaceutical industry, building Africa’s vaccine manufacturing capacity, and building Africa’s quality healthcare infrastructure.”

The statement said that African leaders had called on AfDB to facilitate the establishment of the African Pharmaceutical Technology Foundation.

It said that the AfDB president, who presented the case for the institution to the African Union at the Summit in Addis Ababa in February, said it was a bold initiative.

“Africa can no longer outsource the healthcare security of its 1.3 billion citizens to the benevolence of others.

”With this bold initiative, the African Development Bank has made good on that commitment.

“The decision is a major boost to the health prospects of a continent.

“A continent that has been battered for decades by the burden of several diseases and pandemics such as COVID-19, but with very limited capacity to produce its own medicines and vaccines.”

The statement noted that the World Trade Organisation WTO)and the World Health Organisation (WHO), welcomed the bank’s decision to establish the Foundation.

It quoted the Director-General of the WTO Dr. Ngozi Okonjo-Iweala as saying, “the African Pharmaceutical Technology Foundation is innovative thinking and action by the African Development Bank.

“It provides part of the infrastructure needed to assure an emergent pharmaceutical industry in Africa.”

The statement also quoted the Director-General of WHO, Dr. Tedros Ghebreyesus as saying “establishing the Foundation was a game-changer”.

It also quoted him as saying it was a game-changer “on accelerating access of African pharmaceutical companies to IP-protected technologies and know-how in Africa,”

On activities of the Foundation, the statement said that it would prioritise technologies, products and processes focused primarily on diseases that were widely prevalent in Africa.

It noted that the Foundation would build human and professional skills, research and development ecosystem while supporting upgrade of manufacturing plant capacities and regulatory quality to meet WHO standards.

According to the statement, the African Pharmaceutical Technology Foundation is being established under the auspices of the AfDB.

It stated that the Foundation would operate independently and raise funds from various stakeholders including governments, development finance institutions, and philanthropic organisations among others.

“The Foundation will boost the African Development Bank’s commitment to spend at least three billion dollars over the next 10 years.

“This is to support the pharmaceutical and vaccine manufacturing sector under its Vision 2030 Pharmaceutical Action Plan.

“The Foundation’s areas of work will also be an asset to all other current investments into pharmaceutical production in Africa.

“Rwanda will host the African Pharmaceutical Technology Foundation.

“It will have its own governance and operational structures while promoting and brokering alliances between foreign and African pharmaceutical companies.”

The statement further pointed out that the Foundation would strengthen local pharmaceutical companies to engage in local production initiatives with systematic technology among others.

The Foundation according to the statement, will work with African Union Commission, European Union Commission, WHO and other stakeholders, for collaboration in developed countries and developing countries. 

Excellent journalism is expensive. It is only the same that can help to build our society and country to entrench good governance, and development and ensure justice for all.

We need your support for investigative findings and special reports to demand accountable and transparent government. DONATE today to help us stay relevant to serve your quest for accurate and authentic stories.

DONATE TO 0450702364, naira OR 0657626454, USD – GTBANK


1 Comment

1 Comment

  1. Pingback: Africa to produce 60% of its vaccine need by 2040 - | TechnocratMedia Nigeria

Leave a Reply

Your email address will not be published. Required fields are marked *

Like Our Facebook Page

You May Also Like


African health experts have projected that the continent will produce sixty per cent of its vaccines locally by 2040. 


Publish What You Fund’, the global campaign for aid and development transparency, has ranked the African Development Bank (AfDB) as the most transparent organisation...


Akinwunmi Adesina, President of African Development Bank says the bank is ready to help Nigeria relaunch an electronic wallet system of farm input distribution...


The Board of Directors of the African Development Bank (AfDB) has approved an equity investment of €9.8 million to support venture capital investments in...


The virial caption “If Senator Bola Tinubu could make Lagos the 5th richest economy in Africa and the safest State in Nigeria then be...


Dr Akinwumi Adesina, president of African Development Bank has queried why the developed nations are rushing to ban African countries over the COVID-19 variant,...